Mangoceuticals Inc.
(MGRX)
undefined
undefined%
At close: undefined
2.65
2.32%
After-hours Dec 13, 2024, 07:06 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 |
Revenue | 731.49K | 8.94K | - |
Cost of Revenue | 299.99K | 4.09K | - |
Gross Profit | 431.50K | 4.85K | - |
Operating Income | -9.22M | -1.99M | -17.52K |
Interest Income | - | - | - |
Pretax Income | -9.21M | -2.00M | -17.70K |
Net Income | -9.21M | -2.00M | -17.70K |
Selling & General & Admin | 8.55M | 2.00M | 17.52K |
Research & Development | - | - | - |
Other Expenses | 1.10M | - | - |
Operating Expenses | 9.65M | 2.00M | 17.52K |
Interest Expense | - | 6.47K | 181.00 |
Selling & Marketing Expenses | 2.10M | 352.86K | -52.56K |
Cost & Expenses | 9.95M | 2.00M | 17.52K |
Income Tax | - | -224.62K | -70.08K |
Shares Outstanding (Basic) | 1.43M | 17.32M | 17.32M |
Shares Outstanding (Diluted) | 1.43M | 17.32M | 17.32M |
EPS (Basic) | -6.45 | -0.12 | -0.00 |
EPS (Diluted) | -6.45 | -0.12 | -0.00 |
EBITDA | -9.19M | -1.99M | 52.56K |
Depreciation & Amortization | 24.89K | 3.86K | 70.08K |